Brawn Biotech Ltd

Brawn Biotech Ltd

₹ 20.8 -1.28%
22 Nov - close price
About

Incorporated in 1985, Brawn Biotech Ltd does trading of pharmaceutical products[1]

Key Points

Business Overview:[1][2]
Company is a fully integrated healthcare company having product registration with health and govt. institutions in India and abroad. It deals in Critical Care range of Products along with other Pharmaceutical products. Company's Pharmaceutical Formulations cover all major product segments viz. Anti-bacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti asthmatics, Antacids, Anti-malarial, and Nutritionals

  • Market Cap 6.23 Cr.
  • Current Price 20.8
  • High / Low 27.8 / 14.6
  • Stock P/E
  • Book Value 14.1
  • Dividend Yield 0.00 %
  • ROCE -25.9 %
  • ROE -21.8 %
  • Face Value 10.0

Pros

  • Company is almost debt free.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -24.0% over past five years.
  • Company has a low return on equity of -18.3% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
2.08 2.53 2.89 0.12 7.77 6.31 4.75 7.29 2.92 2.84 3.45 4.06 3.30
2.60 4.08 2.61 0.09 8.11 6.32 4.88 7.45 3.31 3.42 3.84 4.56 3.62
Operating Profit -0.52 -1.55 0.28 0.03 -0.34 -0.01 -0.13 -0.16 -0.39 -0.58 -0.39 -0.50 -0.32
OPM % -25.00% -61.26% 9.69% 25.00% -4.38% -0.16% -2.74% -2.19% -13.36% -20.42% -11.30% -12.32% -9.70%
0.09 0.00 -0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.08 0.00 0.00
Interest 0.05 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.01 0.02 0.02 0.00 0.02 0.03 0.04 0.02 0.03 0.03 0.03 0.03 0.03
Profit before tax -0.49 -1.57 0.16 0.03 -0.36 -0.04 -0.17 -0.18 -0.42 -0.61 -0.34 -0.53 -0.35
Tax % 0.00% 0.00% -293.75% 0.00% -2.78% 0.00% 258.82% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-0.49 -1.57 0.63 0.02 -0.35 -0.04 -0.61 -0.17 -0.42 -0.61 -0.34 -0.53 -0.34
EPS in Rs -1.63 -5.23 2.10 0.07 -1.17 -0.13 -2.03 -0.57 -1.40 -2.03 -1.13 -1.77 -1.13
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
25.70 34.42 38.65 46.88 59.78 55.71 65.18 49.62 34.98 8.53 22.23 16.49 13.65
25.07 33.97 38.09 45.44 58.53 53.75 64.01 48.89 35.58 10.53 22.53 17.95 15.44
Operating Profit 0.63 0.45 0.56 1.44 1.25 1.96 1.17 0.73 -0.60 -2.00 -0.30 -1.46 -1.79
OPM % 2.45% 1.31% 1.45% 3.07% 2.09% 3.52% 1.80% 1.47% -1.72% -23.45% -1.35% -8.85% -13.11%
0.04 -0.07 0.04 0.01 0.61 0.09 0.74 0.17 0.31 0.00 0.01 0.08 0.08
Interest 0.08 0.14 0.10 0.11 0.07 0.06 0.07 0.05 0.04 0.06 0.01 0.06 0.00
Depreciation 0.01 0.01 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.05 0.11 0.10 0.12
Profit before tax 0.58 0.23 0.47 1.31 1.76 1.96 1.81 0.82 -0.36 -2.11 -0.41 -1.54 -1.83
Tax % 37.93% 39.13% 40.43% 27.48% 20.45% 34.69% 26.52% 28.05% 55.56% -22.27% 109.76% -19.48%
0.35 0.14 0.28 0.95 1.39 1.28 1.33 0.59 -0.55 -1.64 -0.87 -1.25 -1.82
EPS in Rs 1.17 0.47 0.93 3.17 4.63 4.27 4.43 1.97 -1.83 -5.47 -2.90 -4.17 -6.06
Dividend Payout % 0.00% 0.00% 0.00% 31.58% 32.37% 23.44% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: -7%
5 Years: -24%
3 Years: -22%
TTM: -36%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -47%
Stock Price CAGR
10 Years: 12%
5 Years: -4%
3 Years: 2%
1 Year: 15%
Return on Equity
10 Years: 2%
5 Years: -10%
3 Years: -18%
Last Year: -22%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00 3.00
Reserves 1.53 1.68 1.94 2.53 3.92 4.63 5.66 6.26 5.79 4.22 3.31 2.06 1.23
0.02 0.01 0.11 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
9.02 9.00 8.95 8.30 10.11 14.94 13.85 11.03 5.08 6.56 8.22 9.53 9.68
Total Liabilities 13.57 13.69 14.00 13.95 17.03 22.57 22.51 20.29 13.87 13.78 14.53 14.59 13.91
0.08 0.07 0.19 0.24 0.25 0.22 0.19 0.18 0.14 0.39 0.37 0.33 0.40
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.03 0.03 0.03 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
13.46 13.59 13.78 13.68 16.78 22.35 22.32 20.11 13.73 13.39 14.16 14.26 13.51
Total Assets 13.57 13.69 14.00 13.95 17.03 22.57 22.51 20.29 13.87 13.78 14.53 14.59 13.91

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.05 0.18 0.23 0.05 1.37 -1.54 0.21 -0.08 0.03 0.19 0.32 -0.03
0.00 -0.01 -0.12 -0.08 0.57 0.00 0.00 -0.02 0.00 -0.30 -0.10 -0.01
-0.08 -0.15 0.00 -0.05 -0.11 -0.06 -0.06 -0.05 -0.04 -0.06 -0.01 0.00
Net Cash Flow -0.03 0.02 0.11 -0.08 1.83 -1.60 0.15 -0.14 0.00 -0.17 0.21 -0.04

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 112.62 88.65 87.07 71.63 79.50 98.60 92.17 110.34 96.83 120.24 87.35 85.88
Inventory Days 35.63 22.14 11.17 4.50 2.59 2.62 2.12 3.38 3.16 261.82 91.20 153.02
Days Payable 147.43 87.79 73.72 44.59 47.70 83.93 64.58 74.47 32.34 224.66 123.19 144.12
Cash Conversion Cycle 0.83 23.01 24.52 31.54 34.39 17.29 29.72 39.25 67.65 157.41 55.36 94.78
Working Capital Days 11.22 15.59 15.87 18.92 28.21 43.37 42.06 58.04 77.53 241.76 80.62 137.90
ROCE % 15.09% 24.89% 11.91% 26.54% 29.28% 27.77% 23.08% 9.71% -3.55% -25.61% -5.91% -25.86%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
53.71% 53.71% 53.73% 53.73% 53.72% 53.72% 53.72% 53.72% 53.72% 53.64% 53.64% 53.64%
0.59% 0.59% 0.59% 0.59% 0.59% 0.59% 0.59% 0.59% 0.59% 0.35% 0.35% 0.35%
45.69% 45.69% 45.68% 45.67% 45.69% 45.69% 45.69% 45.69% 45.69% 46.02% 46.02% 46.02%
No. of Shareholders 6,0826,2886,2846,2816,2756,2226,2466,1946,1394,1604,0904,157

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents